MIND Prize Initiative
The MIND Prize funds bold, high-risk neuroscience research to advance understanding and treatment of neurodegenerative diseases by supporting innovative, independent U.S.-based investigators.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; includes up to 10% indirect costs); at least six awards annually
Summary: Supports bold, high-risk neuroscience research by independent U.S.-based investigators to advance understanding and treatment of brain disorders.
Key Information: One LOI per PI per year; no full proposal stage—finalists present to advisory board.
Description
The MIND Prize Initiative, funded by Pershing Square Philanthropies, empowers early-to-mid-career investigators at U.S. research institutions to pursue innovative, high-risk neuroscience research. The program seeks to catalyze breakthroughs in understanding, predicting, preventing, and treating neurodegenerative diseases (NDDs) by supporting creative scientists willing to challenge conventional paradigms. Projects may span basic or translational neuroscience, including (but not limited to) neurobiology, brain imaging, machine learning, drug delivery, and synthetic biology. The initiative encourages interdisciplinary and collaborative approaches and provides awardees with access to a vibrant network of peers, industry mentors, and special events.
